Morgan Stanley Opiant Pharmaceuticals, Inc. Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.38 - $20.29 $1.79 Million - $3.86 Million	190,441 Added 2640.98%	197,652 $4.01 Million
Q3 2022 Nov 14, 2022	SELL	$9.52 - $13.48 $14,717 - $20,840	-1,546 Reduced 17.65%	7,211 $77,000
Q2 2022 Oct 27, 2022	SELL	$10.12 - $23.32 $181,330 - $417,847	-17,918 Reduced 67.17%	8,757 $105,000
Q2 2022 Aug 15, 2022	SELL	$10.12 - $23.32 $181,330 - $417,847	-17,918 Reduced 67.17%	8,757 $105,000
Q1 2022 Oct 27, 2022	BUY	$19.54 - $33.59 $350,117 - $601,865	17,918 Added 204.61%	26,675 $571,000
Q1 2022 May 13, 2022	SELL	$19.54 - $33.59 $149,695 - $257,332	-7,661 Reduced 22.31%	26,675 $571,000
Q4 2021 Feb 14, 2022	BUY	$22.51 - $36.79 $417,492 - $682,344	18,547 Added 117.47%	34,336 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$13.28 - $25.79 $209,677 - $407,198	15,789 New	15,789 $406,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.